Eli Lilly on Wednesday said its obesity drug Zepbound led to more weight loss than its main rival, Novo Nordisk's Wegovy, in the first head-to-head clinical trial on the weekly injections. The find… [+3457 chars]
EURO 2020 match …
Arrested…
Almost l…
Leave Comments